Vbiosci
Latest round
- Series B
Last raised
- Jun 2023
Total raised
- $31M
Investors
- 14
About Vbiosci
, traing as Vbiosci, is an animal vaccine company that focuses on cell growth technology and biological new drug development. The founder and chairman of the company, Ningning Ma graduated from Ohio State University and has worked in Sino Biological Inc. and Pfizer Inc. The founding team has experience in immunology and animal vaccine development. The company developed a research and development platform technology system from genes to antibody products in the field of animal vaccines that includes new vaccine technology research platform, antibody-drug research platform, and pilot-scale expression platform. Specific products and services include vaccine development, new drug development, and large-scale suspension cell growth technology. It has developed ST, PK-15, Vero and other cells, as well as CHO cell antibody production technology. The pipeline under development includes three sectors, which are poultry, livestock, and pets. Vbiosci also provides products such as cat food and freeze-dried fresh meat pellets. The company generates revenue by providing animal vaccines, pet medicines, and pet products.
Who invested in Vbiosci
14 investors across 4 rounds
See all investors in Vbiosci
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Vbiosci
Who invested in Vbiosci?
Vbiosci has 14 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vbiosci raised?
Vbiosci has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Vbiosci last raise money?
Vbiosci's most recent round on record is a Series B, in Jun 2023.
What does Vbiosci do?
, traing as Vbiosci, is an animal vaccine company that focuses on cell growth technology and biological new drug development.
Where is Vbiosci headquartered?
Vbiosci is headquartered in Beijing, China.
Which VCs invest in companies like Vbiosci?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Vbiosci's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Vbiosci? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.